Komori
Toyota Tsusho (8015) · InitiativeAdvanced

Improving the efficiency of pharmaceutical distribution in India through an investment in SKITES PHARMA

First written in FY2022-Q1. 1 of 3 entries say "Restated". Latest entry: FY2022.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022-Q1 – FY2022-Q22021: 220212022: 12022
Same theme, other companies
Streamlining pharmaceutical distribution in India through investment in SKITES PHARMAA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022AdvancedAnnual report

    「During the fiscal year, the Group advanced the efficiency of pharmaceutical procurement at SAKRA WORLD HOSPITAL, which it operates in India, and began supplying Japanese pharmaceuticals and supplements to the Indian market through SKITES PHARMA, leveraging its knowledge of the hospital's needs.」

    Following its investment in SKITES PHARMA, the Group advanced efforts to improve the efficiency of hospital pharmaceutical procurement and began supplying Japanese pharmaceuticals and supplements to the Indian market.
  2. FY2022-Q2RestatedAnnual report

    「To build a system for delivering necessary pharmaceuticals to hospitals and pharmacies in a timely manner, we invested in India's pharmaceutical wholesaler SKITES PHARMA Private Limited in March 2021. Through the operation of SAKRA WORLD HOSPITAL in India, we will use our knowledge of the needs of hospitals, the buyers of pharmaceuticals, to consolidate and improve the efficiency of pharmaceutical distribution.」

    The Group continues to describe its investment in SKITES PHARMA and the consolidation and streamlining of pharmaceutical distribution using the operational expertise of SAKRA WORLD HOSPITAL.
  3. FY2022-Q1First statedAnnual report

    「To build a system for delivering necessary pharmaceuticals to hospitals and pharmacies in a timely manner, we invested in India's pharmaceutical wholesaler SKITES PHARMA Private Limited in March 2021. Through the operation of SAKRA WORLD HOSPITAL in India, we will use our knowledge of the needs of hospitals, the buyers of pharmaceuticals, to consolidate and improve the efficiency of pharmaceutical distribution.」

    Through its investment in SKITES PHARMA, the Group began consolidating and streamlining pharmaceutical distribution in India by leveraging the operational expertise of SAKRA WORLD HOSPITAL.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Toyota Tsusho's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Improving the efficiency of pharmaceutical distribution in India through an investment in SKITES PHARMA | TOYOTA TSUSHO CORPORATION (8015) | Komori